Beetle Extracellular Vesicles for Efficient dsRNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current techniques for RNA interference (RNAi) in insects result in poor sensitivity and require significant intermediary steps such as isolation and purification of extracellular vesicles (EVs), limiting their efficiency in delivering nucleic acids to target cells.
Innovation Solution
The method involves directly treating cultured beetle cells with long dsRNA, allowing them to secrete nucleic acid-loaded EVs, which are then used to enhance RNAi responses in target cells or organisms, bypassing the need for isolation and purification steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current RNAi techniques are used in insects, then gene expression can be suppressed, but the sensitivity is poor and multiple intermediary steps are required
Solution Approach 1:
The patent uses extracellular vesicles (EVs) as an intermediary carrier to deliver dsRNA to target cells. The EVs are naturally secreted by beetle cells after dsRNA treatment, and they mediate the transfer of nucleic acids to target cells, improving delivery efficiency while simplifying the overall process by eliminating manual isolation and purification steps
Solution Approach 2:
The beetle cells automatically produce and secrete EVs containing the nucleic acid cargo when treated with dsRNA. This self-service mechanism allows the system to generate its own delivery vehicles without requiring external intervention for EV isolation and purification, thereby reducing process complexity while maintaining high RNAi efficiency
2Reliability
If extracellular vesicles are isolated and purified through intermediary steps, then delivery vehicles are obtained, but the process requires significant time and resources
Solution Approach 1:
The patent extracts only the essential functional component (EVs with nucleic acid cargo) directly from the beetle cell culture supernatant without requiring complex isolation and purification procedures. This selective extraction approach maintains delivery efficiency while dramatically reducing processing time by eliminating unnecessary intermediary steps
3Reliability
If high amounts of nucleic acid are used for direct treatment, then some RNAi effect is achieved, but the efficiency is limited and requires large quantities
Solution Approach 1:
The patent changes the delivery parameter from direct dsRNA application to EV-mediated delivery. This parameter change allows the system to achieve the same or better gene suppression efficiency using substantially lower amounts of nucleic acid, as the EVs protect and efficiently deliver the cargo to target cells, enhancing the biological activity per unit of nucleic acid
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances RNAi efficiency by increasing suppression of target gene expression by at least 30-100% compared to direct dsRNA treatment, using substantially lower nucleic acid amounts.
Implementation Method 1
RNA interference or 'RNAi' is a process of sequence-specific down-regulation of gene expression (also referred to as 'gene silencing' or 'RNA-mediated gene silencing'), usually initiated by double-stranded RNA (dsRNA) that is complementary in sequence to a region of the target gene to be down-regulated.
Implementation Method 2
The present invention is broadly concerned with composition for delivery of nucleic acids, such as for inhibition of a target gene in a target organism or cell. The compositions generally comprise a plurality of beetle extracellular vesicles, each extracellular vesicle comprising a nucleic acid molecule
Data Source
AI summary
Nucleic acid delivery vehicles for delivering nucleic acid, e.g., for RNAi to cells that are typically refractory to RNAi by using extracellular vesicles (EVs) from cultured beetle cells as delivery vehicles. Instead of using high levels of long dsRNA and transfection reagents to accomplish suppression of an mRNA target in cells that don't respond to treatment with naked dsRNA, this approach applies the dsRNA to cultured beetle cells, collects nucleic-acid loaded EVs from the culture, then treats our target cells with the intracellularly loaded EVs, which results in significant enhancement of the RNAi response and greater suppression of transcript levels.